Pharmaceutical

STAT+: FDA approves first treatment for skin condition ...

The FDA approved the first treatment for dystrophic epidermolysis bullosa, a dev...

STAT+: Novo Nordisk pauses ads for weight loss drug Weg...

The company behind the weight-loss-inducing drugs Ozempic and Wegovy is pausing ...

STAT+: FDA official offers insights into whether gene t...

The FDA is thinking about a groundbreaking approach to making gene therapies tha...

STAT+: Pear Therapeutics sold for parts at $6 million a...

Four companies agreed to buy the assets of Pear Therapeutics at auction after th...

STAT+: Pharmalittle: AstraZeneca plans to ‘love’ China’...

The U.S. Supreme Court upheld a ruling that Amgen failed to disclose sufficient ...

After decades of neglecting women athletes, sport and e...

Sports medicine has long neglected research on female athletes, putting them at ...

Opinion: Chelsea Clinton: How to eliminate viral hepati...

Viral hepatitis affects almost 400 million people and kills more than 1 million ...

Opinion: How I helped Pfizer think through the ethics o...

What it was like advising Pfizer on the ethics of Viagra in 1998.

Gene therapy death not caused by CRISPR, investigators ...

Investigators found Terry Horgan did not die as a result of CRISPR itself, but r...

FDA advisory panel backs Pfizer’s RSV vaccine, but expr...

A committee of vaccine experts voted to recommend the FDA approve Pfizer’s mater...

Listen: The FTC v. Amgen, Sarepta’s future, & Galapagos...

Does the FTC have it out for pharma? What does it take to make an RSV vaccine? A...

Soft, stretchable electronic skin could reconstruct the...

A Stanford team has built soft, stretchable electronic skin that aims to restore...

After new cluster, health officials warn mpox could res...

Mpox has “a substantial risk of resurgence” health officials say, warning people...

STAT+: Supreme Court rules against Amgen in closely wat...

U.S. Supreme Court has ruled against Amgen in a patent case that had the entire ...

STAT+: New Biden science agency ARPA-H launches first p...

A multibillion-dollar science agency tasked with slashing through research burea...

STAT+: Pharmalittle: Appellate judges appear skeptical ...

A federal appeals court panel heard arguments in a case that could determine the...